Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7779]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab
Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA
Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab ( Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA )
3 Jun 2013
Nivolumab blocking PD1 in lung cancer and melanoma
Dr Suzanne Topalian - Johns Hopkins Medical Center, Baltimore, USA
Nivolumab blocking PD1 in lung cancer and melanoma ( Dr Suzanne Topalian - Johns Hopkins Medical Center, Baltimore, USA )
3 Jun 2013
Nintedanib in combination with standard second line therapy in lung cancer
Dr Martin Reck - Hospital Grosshansdorf, Wohrendamm, Germany
Nintedanib in combination with standard second line therapy in lung cancer ( Dr Martin Reck - Hospital Grosshansdorf, Wohrendamm, Germany )
3 Jun 2013
The problem of unnecessary treatment of prostate cancer
Dr Rosalind Eeles - Royal Marsden Hospital, London, UK
The problem of unnecessary treatment of prostate cancer ( Dr Rosalind Eeles - Royal Marsden Hospital, London, UK )
3 Jun 2013
Ganetespib inhibits Hsp90 effective as second-line therapy with docetaxel for...
Dr Suresh S. Ramalingam - Emory University, Atlanta, USA
Ganetespib inhibits Hsp90 effective as second-line therapy with docetaxel for advanced lung cancer ( Dr Suresh S. Ramalingam - Emory University, Atlanta, USA )
3 Jun 2013
Paclitaxel chemotherapy schedules are equally effective for early-stage breast...
Dr G. Thomas Budd - MD Cleveland Clinic, USA
Paclitaxel chemotherapy schedules are equally effective for early-stage breast cancer ( Dr G. Thomas Budd - MD Cleveland Clinic, USA )
3 Jun 2013
Selumetinib, the first effective drug for advanced melanoma of the eye
Dr Richard Carvajal - Memorial Sloan Kettering Cancer Center, New York, USA
Selumetinib, the first effective drug for advanced melanoma of the eye ( Dr Richard Carvajal - Memorial Sloan Kettering Cancer Center, New York, USA )
3 Jun 2013
Development and clinical trials of Z100
Dr Keiichi Fujiwara - Saitama Medical University, Saitama, Japan
Development and clinical trials of Z100 ( Dr Keiichi Fujiwara - Saitama Medical University, Saitama, Japan )
3 Jun 2013
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer
Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer ( Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA )
2 Jun 2013
Extended use of tamoxifen reduces breast cancer recurrence and death
Prof Richard Gray - University of Oxford, Oxford, United Kingdom
Extended use of tamoxifen reduces breast cancer recurrence and death ( Prof Richard Gray - University of Oxford, Oxford, United Kingdom )
2 Jun 2013
Ipilimumab and BRAF inhibitors for advanced melanoma
Dr Lynn Schuchter - University of Pennsylvania, USA
Ipilimumab and BRAF inhibitors for advanced melanoma ( Dr Lynn Schuchter - University of Pennsylvania, USA )
2 Jun 2013
Effect of metformin on cancer risk and mortality
Dr Sara Gandini - European Institute of Oncology (IEO), Milan, Italy
Effect of metformin on cancer risk and mortality ( Dr Sara Gandini - European Institute of Oncology (IEO), Milan, Italy )
2 Jun 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation